Self-assembly, cytocompatibility, and interactions of desmopressin with sodium polystyrene sulfonate

Autor(es):Mostrar menos -

Caliari, Ana B. ; Bicev, Renata N. ; da Silva, Caroline C. ; de Souza, Sinval E. G. ; da Silva, Marta G. ; Souza, Louise E. A. ; de Mello, Lucas R. ; Hamley, Ian W. ; Motta, Guacyara ; Degrouard, Jeril ; Tresset, Guillaume ; Quaresma, Alexandre J. C. ; Nakaie, Clovis R. ; da Silva, Emerson R.

• Tipo de documento: Artigo Científico
• Fonte: SOFT MATTER; v. N/A, p. 17-pg., 2024-11-19.

Resumo

Peptide-polymer systems hold strong potential for applications in nanotherapeutics. Desmopressin, a synthetic analogue of the antidiuretic hormone arginine vasopressin, may serve as a valuable case of study in this context since it is a first-line treatment for disorders affecting water homeostasis, including diabetes insipidus. It also has an established use as a hemostatic agent in von Willebrand disease, and recently, its repurposing has been suggested as a neoadjuvant in the treatment of certain types of cancer. Despite its well-documented clinical uses, studies on the supramolecular organization of desmopressin and its association with polymers remain scarce, limiting the therapeutic benefits of these nanostructured arrays. Here, we investigate the self-assembly of desmopressin and its association with sodium polystyrene sulphonate (NaPSS), a potassium-binding polymer used to treat hyperkalemia. Using structural techniques such as small-angle X-ray scattering (SAXS), cryogenic transmission electron microscopy (cryo-TEM), and atomic force microscopy combined with infrared nanospectroscopy (AFM-IR), we identified that desmopressin associates with NaPSS to form hybrid fibrillar nanoassemblies characterized by beta-turn enriched domains and the appearance of beta-sheet content. In vitro cytotoxicity assays conducted on breast cancer cell lines MCF-7 and MDA-MB-231 showed that NaPSS/desmopressin complexes are well-tolerated by the non-metastatic MCF-7 cells while displaying inhibitory effects against the metastatic MDA-MB-231 cells. The findings presented here, which demonstrate the successful association between two clinically validated drugs and the ability of the hybrid matrix to modulate cell interactions, potentially contribute to the design of peptide-polymer therapeutic systems. (AU)

• Processo FAPESP: 21/04885-3 - Síntese e investigação estrutural de peptídeos e de polímeros: da inovações no método da síntese ao estudo de alguns peptídeos de relevância fisiológica
• Beneficiário: Clovis Ryuichi Nakaie
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 22/03056-6 - Caracterização ultraestrutural de nanoscaffolds bioativos
• Beneficiário: Emerson Rodrigo da Silva
• Modalidade de apoio: Auxílio à Pesquisa - Projeto Inicial
• Processo FAPESP: 23/18385-8 - Coacervados Bioinspirados Baseados em Peptídeos Bioativos Derivados de Proteomas Virais
• Beneficiário: Emerson Rodrigo da Silva
• Modalidade de apoio: Bolsas no Exterior - Pesquisa
• Processo FAPESP: 17/22047-0 - Interação entre Integrinas e o Receptor de Uroquinase (uPAR): participação do Sistema Calicreína-Cinina Plasmático e Proteoglicanos.
• Beneficiário: Guacyara da Motta
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 19/19719-1 - Matrizes peptídicas bioativas: da estrutura molecular às aplicações biomédicas
• Beneficiário: Lucas Rodrigues de Mello
• Modalidade de apoio: Bolsas no Brasil - Doutorado